5409-15-4 Usage
Uses
Used in Chemical Synthesis:
4-Chloro-1-hydroxy-2-naphthoic acid is used as a key intermediate in the chemical industry for the synthesis of various complex organic molecules. Its reactivity and functional groups make it a valuable component in the formation of new compounds.
Used in Pharmaceutical Industry:
4-Chloro-1-hydroxy-2-naphthoic acid is used as a building block in the development of pharmaceutical compounds. Its unique structure and functional groups allow for the creation of new drugs with potential therapeutic applications.
Used in Dye Production:
In the dye industry, 4-chloro-1-hydroxy-2-naphthoic acid is used as a precursor for the production of various dyes. Its chemical properties enable the creation of dyes with specific color characteristics and stability.
Used in Pesticide Formulation:
4-Chloro-1-hydroxy-2-naphthoic acid is used as a component in the formulation of certain pesticides. Its chemical properties contribute to the effectiveness of these products in controlling pests and protecting crops.
Check Digit Verification of cas no
The CAS Registry Mumber 5409-15-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,0 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5409-15:
(6*5)+(5*4)+(4*0)+(3*9)+(2*1)+(1*5)=84
84 % 10 = 4
So 5409-15-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H7ClO3/c12-9-5-8(11(14)15)10(13)7-4-2-1-3-6(7)9/h1-5,13H,(H,14,15)
5409-15-4Relevant academic research and scientific papers
INHIBITORS OF CXCR2
-
Page/Page column 60, (2008/06/13)
The invention relates to compounds of the formula (I), in which R1, R2, X, A, B and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula (I) and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
NEW CXCR2 INHIBITORS
-
Page/Page column 155-156, (2008/06/13)
The invention relates to compounds of the formula (I), in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
